Search Results - "WITTWER, Matthias"

Refine Results
  1. 1

    Fundamental aspects of DMPK optimization of targeted protein degraders by Cantrill, Carina, Chaturvedi, Prasoon, Rynn, Caroline, Petrig Schaffland, Jeannine, Walter, Isabelle, Wittwer, Matthias B.

    Published in Drug discovery today (01-06-2020)
    “…•Degraders are an emerging modality which fall into the ‘beyond rule of 5’ space.•Poor permeability and solubility are critical features limiting oral…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Considerations and recommendations for assessment of plasma protein binding and drug-drug interactions for siRNA therapeutics by Humphreys, Sara C, Davis, John A, Iqbal, Sajida, Kamel, Amin, Kulmatycki, Kenneth, Lao, Yanbin, Liu, Xiumin, Rodgers, John, Snoeys, Jan, Vigil, Adam, Weng, Yan, Wiethoff, Christopher M, Wittwer, Matthias B

    Published in Nucleic acids research (24-06-2022)
    “…At the time of writing, although siRNA therapeutics are approved for human use, no official regulatory guidance specific to this modality is available. In the…”
    Get full text
    Journal Article
  4. 4

    Renal Transporters in Drug Development by MORRISSEY, Kari M, STOCKER, Sophie L, WITTWER, Matthias B, LU XU, GIACOMINI, Kathleen M

    “…The kidney plays a vital role in the body's defense against potentially toxic xenobiotics and metabolic waste products through elimination pathways. In…”
    Get full text
    Journal Article
  5. 5

    Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance by Zamek‐Gliszczynski, Maciej J., Sangha, Vishal, Shen, Hong, Feng, Bo, Wittwer, Matthias B., Varma, Manthena V. S., Liang, Xiaomin, Sugiyama, Yuichi, Zhang, Lei, Bendayan, Reina

    Published in Clinical pharmacology and therapeutics (01-09-2022)
    “…During its fourth transporter workshop in 2021, the International Transporter Consortium (ITC) provided updates on emerging clinically relevant transporters…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The genome of Naegleria lovaniensis, the basis for a comparative approach to unravel pathogenicity factors of the human pathogenic amoeba N. fowleri by Liechti, Nicole, Schürch, Nadia, Bruggmann, Rémy, Wittwer, Matthias

    Published in BMC genomics (05-09-2018)
    “…Members of the genus Naegleria are free-living eukaryotes with the capability to transform from the amoeboid form into resting cysts or moving flagellates in…”
    Get full text
    Journal Article
  8. 8

    Targeted protein degraders: a call for collective action to advance safety assessment by Jones, Lyn H., Mitchell, Constance A., Loberg, Lise, Pavkovic, Mira, Rao, Mohan, Roberts, Ruth, Stamp, Katie, Volak, Laurie, Wittwer, Matthias B., Pettit, Syril

    Published in Nature reviews. Drug discovery (01-06-2022)
    “…Targeted protein degraders (TPDs) are emerging classes of therapeutics that have the potential to address difficult drug targets in new ways. In 2021, experts…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Identification of cryptic Anopheles mosquito species by molecular protein profiling by Müller, Pie, Pflüger, Valentin, Wittwer, Matthias, Ziegler, Dominik, Chandre, Fabrice, Simard, Frédéric, Lengeler, Christian

    Published in PloS one (28-02-2013)
    “…Vector control is the mainstay of malaria control programmes. Successful vector control profoundly relies on accurate information on the target mosquito…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature by Kemble, Alicia M, Hornsperger, Benoit, Ruf, Iris, Richter, Hans, Benz, Jörg, Kuhn, Bernd, Heer, Dominik, Wittwer, Matthias, Engelhardt, Britta, Grether, Uwe, Collin, Ludovic

    Published in PloS one (09-09-2022)
    “…Chronic inflammation and blood–brain barrier dysfunction are key pathological hallmarks of neurological disorders such as multiple sclerosis, Alzheimer’s…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration by Zysset-Burri, Denise C., Keller, Irene, Berger, Lieselotte E., Largiadèr, Carlo R., Wittwer, Matthias, Wolf, Sebastian, Zinkernagel, Martin S.

    Published in Npj genomic medicine (01-09-2020)
    “…Age-related macular degeneration (AMD) is a leading cause of severe vision loss in the aged population. The etiology of AMD is multifactorial including…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Functional characterization of Francisella tularensis subspecies holarctica genotypes during tick cell and macrophage infections using a proteogenomic approach by Schütz, Sara Doina, Brackmann, Maximilian, Liechti, Nicole, Moser, Michel, Wittwer, Matthias, Bruggmann, Rémy

    “…Tularemia is a vector-borne disease caused by the Gram-negative bacterium . Known hosts and vectors in Europe are hare and ticks. is transmitted from ticks and…”
    Get full text
    Journal Article